Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Boeing
BA
|
$1.32B |
| 2 |
PNC Financial Services
PNC
|
$894M |
| 3 |
Netflix
NFLX
|
$852M |
| 4 |
UnitedHealth
UNH
|
$676M |
| 5 |
Northrop Grumman
NOC
|
$672M |
Top Sells
| 1 |
Wells Fargo
WFC
|
$1.18B |
| 2 |
Amgen
AMGN
|
$769M |
| 3 |
Texas Instruments
TXN
|
$602M |
| 4 |
AbbVie
ABBV
|
$505M |
| 5 |
Verizon
VZ
|
$476M |
Sector Composition
| 1 | Technology | 20.3% |
| 2 | Healthcare | 15.12% |
| 3 | Financials | 13.11% |
| 4 | Communication Services | 11.57% |
| 5 | Industrials | 11.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Old Dominion Freight Line
ODFL
$31.7B
| $744M | 0.28% | 4,378,948 +2,028,847 | +86% | +$345M |
|
102
AstraZeneca
AZN
$248B
| $741M | 0.28% | 16,630,274 +3,500 | +0% | +$156K |
|
103
Lockheed Martin
LMT
$106B
| $733M | 0.28% | 1,880,407 +676,309 | +56% | +$264M |
|
104
Canadian Natural Resources
CNQ
$65.9B
| $703M | 0.27% | 26,419,500 +2,028,408 | +8% | +$54M |
|
105
Vale
VALE
$43.9B
| $699M | 0.27% | 60,789,418 +242,847 | +0.4% | +$2.79M |
|
106
Adobe
ADBE
$151B
| $689M | 0.26% | 2,493,221 +985,461 | +65% | +$272M |
|
107
Incyte
INCY
$16.5B
| $677M | 0.26% | 9,123,877 +137,466 | +2% | +$10.2M |
|
108
VeriSign
VRSN
$25.5B
| $604M | 0.23% | 3,200,557 -1,599,443 | -33% | -$302M |
|
109
Blackstone
BX
$134B
| $603M | 0.23% | 12,347,878 +507,438 | +4% | +$24.8M |
|
110
Trimble
TRMB
$19.2B
| $602M | 0.23% | 15,523,949 -631,329 | -4% | -$24.5M |
|
111
United Parcel Service
UPS
$74.1B
| $599M | 0.23% | 5,002,615 +51 | +0% | +$6.11K |
|
112
Church & Dwight Co
CHD
$22.7B
| $598M | 0.23% | 7,942,717 -328,171 | -4% | -$24.7M |
|
113
Thermo Fisher Scientific
TMO
$186B
| $588M | 0.22% | 2,019,941 -522,631 | -21% | -$152M |
|
114
America Movil
AMX
$60.3B
| $561M | 0.21% | 37,734,956 +4,897,045 | +15% | +$72.8M |
|
115
Procter & Gamble
PG
$368B
| $552M | 0.21% | 4,434,418 +546,926 | +14% | +$68M |
|
116
Baker Hughes
BKR
$44.8B
| $550M | 0.21% | 23,704,458 +8,006,663 | +51% | +$186M |
|
117
Neurocrine Biosciences
NBIX
$13.8B
| $525M | 0.2% | 5,830,476 +200,122 | +4% | +$18M |
|
118
S&P Global
SPGI
$167B
| $525M | 0.2% | 2,143,468 +880,226 | +70% | +$216M |
|
119
State Street
STT
$32.6B
| $524M | 0.2% | 8,860,427 -4,756,553 | -35% | -$282M |
|
|
SAGE
120
DELISTED
Sage Therapeutics
SAGE
| $513M | 0.2% | 3,657,016 +516,724 | +16% | +$72.5M |
|
121
Vertex Pharmaceuticals
VRTX
$100B
| $512M | 0.2% | 3,023,390 +123 | +0% | +$20.8K |
|
122
Willis Towers Watson
WTW
$31.9B
| $502M | 0.19% | 2,603,798 +239,609 | +10% | +$46.2M |
|
|
BLUE
123
DELISTED
bluebird bio
BLUE
| $500M | 0.19% | 5,440,344 +351,340 | +7% | +$32.3M |
|
124
Mastercard
MA
$538B
| $499M | 0.19% | 1,836,844 +118,861 | +7% | +$32.3M |
|
125
Williams Companies
WMB
$70.7B
| $493M | 0.19% | 20,479,400 -2,496,513 | -11% | -$60.1M |
|